Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
RADIation ONcology-Devices from Opwijk, company number BE0740913516, closed financial year 2025 with a result of € -13,083 after tax. For that financial year RADIation ONcology-Devices recorded a gross margin of € -12,461 and equity of € -6,694. Compared with financial year 2024, the result moved from € 587 to € -13,083. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ -6,694
▼ € 13,083 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -13,083
▼ still € 587 profit in 2024
Profit after tax over the fiscal year.
€ 81,505
▼ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -11,694.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,819
▼ 86% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 110
▼ 88% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 42,667 | € 19,483 | € 1,514 | € -12,461 | ▼ € 13,975 |
| Profit after taxes | € 119 | € -1,392 | € 587 | € -13,083 | ▼ € 13,670 |
| Equity | € 7,194 | € 5,802 | € 6,389 | € -6,694 | ▼ € 13,083 |
| Total debts | € 80,179 | € 138,254 | € 149,034 | € 129,386 | ▼ 13% |
| Cash | € 36,493 | € 54,724 | € 104,718 | € 81,505 | ▼ 22% |
| Retained profit | € 2,194 | € 802 | € 1,389 | € -11,694 | ▼ € 13,083 |
| Balance sheet total | € 87,373 | € 144,056 | € 155,423 | € 122,692 | ▼ 21% |
Key figures of RADIation ONcology-Devices, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to RADIation ONcology-Devices?
What happened at RADIation ONcology-Devices in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 13,083 (▼ € 13,670 vs 2024). Source: NBB ↗
- Exploration BV became a director. NBB
- New establishment in Opwijk. KBO
- Wilfried De Neve became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 119 profit in 2022 to € 13,083 loss in 2025.
Paid € 493 in corporate taxes since 2022.
Best year ever: 2024, with € 587 profit.
A new publication or filing at RADIation ONcology-Devices? We notify you, reason included.
Follow RADIation ONcology-DevicesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind RADIation ONcology-Devices are Exploration BV and Wilfried De Neve. Exploration BV is also behind ROSIER and YUN. Wilfried De Neve is also behind ASSOCIATION BELGE CONTRE LE CANCER, OEUVRE BELGE DU CANCER, FEDERATION BELGE CONTRE LE CANCER-BELGISCHE FEDERATIE TEGEN KANKER-BELGISCHE FÖDERATION GEGEN KREKS-BELGIAN FEDERATION AGAINST CANCER and FONDATION CONTRE LE CANCER.
Directors
According to the 2025 annual accounts
since 2021
Wilfried De Neve
Administrator-manager
Also active at: ASSOCIATION BELGE CONTRE LE CANCER, OEUVRE BELGE DU CANCER, FEDERATION BELGE CONTRE LE CANCER-BELGISCHE FEDERATIE TEGEN KANKER-BELGISCHE FÖDERATION GEGEN KREKS-BELGIAN FEDERATION AGAINST CANCER, FONDATION CONTRE LE CANCER
since 2020
Establishments
Establishment units
Physical locations of this company
Langeveldstraat 70
1745 Opwijk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0740.913.516
- VAT number
- BE 0740.913.516
- Registered office
- Langeveldstraat 70, 1745 Opwijk
- Names & denominations
- RADIation ONcology-Devices · RADION-D
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 January 2020
- Peppol
- Active · Active since 30 Jan 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht
Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels